Skip to main content

Infantile Hemangiomas of the Eyelids and Orbit

  • Chapter
  • First Online:
Vascular Lesions of the Orbit and Face

Abstract

Infantile hemangiomas are the most common vascular tumor seen in infants. They typically appear in the first few weeks of life [1–3] and occur in 4–12 % of infants [4]. When located in the periocular and orbital region, hemangiomas have the potential to affect the developing vision of infants, causing amblyopia. Multiple treatment modalities have been offered for treatment of infantile hemangiomas including topical, intralesional, and systemic steroids; more recently, the use of oral propranolol has been successful in treating these lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haik BG, et al. Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmol. 1994;38(5):399–426.

    Article  CAS  PubMed  Google Scholar 

  2. Rosca TI, et al. Vascular tumors in the orbit–capillary and cavernous hemangiomas. Ann Diagn Pathol. 2006;10(1):13–9.

    Article  PubMed  Google Scholar 

  3. Ni N, Guo S, Langer P. Current concepts in the management of periocular infantile (capillary) hemangioma. Curr Opin Ophthalmol. 2011;22(5):419–25.

    Article  PubMed  Google Scholar 

  4. Frank RC, et al. Visual development in infants: visual complications of periocular haemangiomas. J Plast Reconstr Aesthet Surg. 2010;63(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  5. Schwartz SR, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS. 2006;10(3):262–8.

    Article  PubMed  Google Scholar 

  6. Kavanagh EC, et al. Imaging of the natural history of an orbital capillary hemangioma. Orbit. 2006;25(1):69–72.

    Article  PubMed  Google Scholar 

  7. Takahashi K, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest. 1994;93(6):2357–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Buerger DV, Saunders DH, Flanagan JC, Nelson LB. Chapter 17: Disorders of the Eyelids. Harley’s pediatric ophthalmology. 4th ed. Philadelphia: Elsevier Health Sciences Division: 1988. p. 353–370.

    Google Scholar 

  9. Ellis FD. Lid malformations, malpositions, and lesions. In: Pediatric ophthalmology and strabismus. 2nd ed. New York: Springer; 2002. p. 299–312.

    Google Scholar 

  10. Goggin M. Astigmatism and periocular hemangioma. Ophthalmology. 2008;115(10):1854–5. author reply 1855.

    Article  PubMed  Google Scholar 

  11. Mohanan S, Besra L, Chandrasekhar L, Thappa DM. Indian J Dermatol Venereol Leprol. 2012;78:114–5.

    Article  PubMed  Google Scholar 

  12. Hartemink DA, et al. PHACES syndrome: a review. Int J Pediatr Otorhinolaryngol. 2009;73(2):181–7.

    Article  PubMed  Google Scholar 

  13. Jockin YM, Friedlander SF. Periocular infantile hemangioma. Int Ophthalmol Clin. 2010;50(4):15–25.

    Article  PubMed  Google Scholar 

  14. Schwartz SR, et al. Treatment of capillary hemangiomas causing refractive and occlusional amblyopia. J AAPOS. 2007;11(6):577–83.

    Article  PubMed  Google Scholar 

  15. Cruz OA, Zarnegar SR, Myers SE. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology. 1995;102(12):2012–5.

    Article  CAS  PubMed  Google Scholar 

  16. Elsas FJ, Lewis AR. Topical treatment of periocular capillary hemangioma. J Pediatr Ophthalmol Strabismus. 1994;31(3):153–6.

    CAS  PubMed  Google Scholar 

  17. Kushner BJ. Intralesional corticosteroid injection for infantile adnexal hemangioma. Am J Ophthalmol. 1982;93(4):496–506.

    Article  CAS  PubMed  Google Scholar 

  18. O’Keefe M, Lanigan B, Byrne SA. Capillary haemangioma of the eyelids and orbit: a clinical review of the safety and efficacy of intralesional steroid. Acta Ophthalmol Scand. 2003;81(3):294–8.

    Article  PubMed  Google Scholar 

  19. Friling R, et al. Intralesional and sub-Tenon’s infusion of corticosteroids for treatment of refractory periorbital and orbital capillary haemangioma. Eye (Lond). 2009;23(6):1302–7.

    Article  CAS  Google Scholar 

  20. Shorr N, Seiff SR. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg. 1986;17(4):229–31.

    CAS  PubMed  Google Scholar 

  21. Weiss AH. Adrenal suppression after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol. 1989;107(5):518–22.

    Article  CAS  PubMed  Google Scholar 

  22. Yuan SM, et al. Intralesional injection of diprospan is effective for infantile hemangioma. J Craniofac Surg. 2015;26(2):422–4.

    Article  PubMed  Google Scholar 

  23. Boon LM, MacDonald DM, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104(6):1616–23.

    Article  CAS  PubMed  Google Scholar 

  24. Barlow CF, et al. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. J Pediatr. 1998;132(3 Pt 1):527–30.

    Article  CAS  PubMed  Google Scholar 

  25. Martinez MI, et al. Infantile hemangioma: clinical resolution with 5% imiquimod cream. Arch Dermatol. 2002;138(7):881–4; discussion 884.

    Article  PubMed  Google Scholar 

  26. Levi M, et al. Surgical treatment of capillary hemangiomas causing amblyopia. J AAPOS. 2007;11(3):230–4.

    Article  PubMed  Google Scholar 

  27. Deans RM, Harris GJ, Kivlin JD. Surgical dissection of capillary hemangiomas: an alternative to intralesional corticosteroids. Arch Ophthalmol. 1992;110(12):1743–7.

    Article  CAS  PubMed  Google Scholar 

  28. Itani MH, Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Rep. 2009;2009:bcr0120091476.

    Google Scholar 

  29. Léauté-Labrèze C, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51.

    Article  PubMed  Google Scholar 

  30. Taban M, Goldberg RA. Propranolol for orbital hemangioma. Ophthalmology. 2010;117(1):195–195.e4.

    Article  PubMed  Google Scholar 

  31. Sans V, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124(3):e423–31.

    Article  PubMed  Google Scholar 

  32. Manunza F, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol. 2010;162(2):466–8.

    Article  CAS  PubMed  Google Scholar 

  33. Marsciani A, et al. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer. 2010;54(1):176.

    Article  PubMed  Google Scholar 

  34. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med. 2008;359(26):2846. author reply 2846–7.

    Article  CAS  PubMed  Google Scholar 

  35. Léauté-Labrèze C, Taieb A. Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol. 2008;135(12):860–2.

    Article  PubMed  Google Scholar 

  36. Léauté-Labrèze C, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372(8):735–46.

    Article  PubMed  Google Scholar 

  37. Fridman G, et al. Propranolol for the treatment of orbital infantile hemangiomas. Ophthal Plast Reconstr Surg. 2011;27(3):190–4.

    PubMed  Google Scholar 

  38. Mai C, et al. Successful treatment of orbital capillary hemangioma with propranolol. Ophthalmologe. 2011;108(4):364–7.

    Article  CAS  PubMed  Google Scholar 

  39. Meena M. Propranolol for the treatment of orbital infantile hemangiomas. Ophthal Plast Reconstr Surg. 2011;27(5):392. author reply 393.

    Article  PubMed  Google Scholar 

  40. Aly MM, et al. Therapeutic superiority of combined propranolol with short steroids course over propranolol monotherapy in infantile hemangioma. Eur J Pediatr. 2015.

    Google Scholar 

  41. Abarzua-Araya A, et al. Atenolol versus propranolol for the treatment of infantile hemangiomas: a randomized controlled study. J Am Acad Dermatol. 2014;70(6):1045–9.

    Article  CAS  PubMed  Google Scholar 

  42. Ni N, et al. Topical timolol for periocular hemangioma: report of further study. Arch Ophthalmol. 2011;129(3):377–9.

    Article  PubMed  Google Scholar 

  43. Xu DP, et al. Topical timolol maleate for superficial infantile hemangiomas: an observational study. J Oral Maxillofac Surg. 2015;73(6):1089–94.

    Article  PubMed  Google Scholar 

  44. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38(5):298–304.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kimberly G. Yen M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hussein, M.A., Yen, K.G. (2016). Infantile Hemangiomas of the Eyelids and Orbit. In: Yen, M. (eds) Vascular Lesions of the Orbit and Face. Springer, Cham. https://doi.org/10.1007/978-3-319-29704-0_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29704-0_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29702-6

  • Online ISBN: 978-3-319-29704-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics